12:00 AM
Jan 11, 2016
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Staccato alprazolam: Interim Phase IIa data

Interim data from 3 epileptics with acute repetitive seizures in a double-blind, crossover, U.S. Phase IIa trial showed that single doses of 0.5, 1 and 2 mg inhaled AZ-002 led to dose-related reductions in mean photosensitivity response, the primary endpoint, as measured by SPR. The trial used an intermittent photic sensitivity (IPS) model in patients with...

Read the full 257 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >